HIGHLIGHTS
- who: Qing Ji and collaborators from the Department of Rare and Head and Neck Oncology, Key Laboratory of Head and Neck Cancer Translational Research of Zhejiang Province, The Cancer Hospital of the University of Chinese Academy Chinese Academy of Sciences, Hangzhou, China have published the research work: Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches, in the Journal: Pharmaceutics 2022, 14, 1811. of /2022/
- what: Oncolytic virotherapy is a promising immunotherapy for malignancies and has also shown promising therapeutic potential in clinical trials.
- how: This review introduces the latest progress . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.